| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥28.2B | ¥28.6B | -1.4% |
| Operating Income | ¥3.5B | ¥1.4B | +149.9% |
| Ordinary Income | ¥3.4B | ¥1.1B | +196.1% |
| Net Income | ¥2.3B | ¥0.6B | +290.7% |
| ROE | 10.0% | 2.8% | - |
FY2025 Q1 results: Revenue 28.2B yen (YoY -1.4%), Operating Income 3.5B yen (YoY +149.9%), Ordinary Income 3.4B yen (YoY +196.1%), Net Income 2.3B yen (YoY +290.7%). The quarter demonstrated significant profit expansion despite essentially flat revenue, driven by substantial margin improvement. Operating margin reached 12.4%, marking a notable improvement from the prior year. However, this earnings growth occurred alongside a concerning deterioration in working capital efficiency, with accounts receivable increasing 49.1% and inventory maintaining elevated levels. Short-term borrowings surged six-fold to 7.0B yen, raising questions about cash flow quality and refinancing requirements despite strong reported profitability.
Revenue of 28.2B yen declined marginally by 1.4% YoY, indicating flat demand conditions in the company's markets. Despite the top-line stagnation, gross profit margin reached 38.1%, contributing to strong profitability. Operating income expanded 149.9% to 3.5B yen, with operating margin improving significantly to 12.4% from approximately 5.0% in the prior year period. This dramatic margin expansion suggests successful cost control measures or favorable product mix shifts. The progression from operating income to ordinary income showed minimal variance, with non-operating expenses including foreign exchange losses of 11M yen and interest expenses of 2M yen having limited impact. Ordinary income of 3.4B yen represented a 196.1% increase YoY. Net income of 2.3B yen surged 290.7%, yielding a net margin of 8.3%. The effective tax rate of 28.6% was within normal parameters. The company achieved a revenue flat/profit up pattern, demonstrating operational leverage through margin improvement despite challenging top-line conditions.
[Profitability] ROE of 10.0% represents a strong improvement, driven primarily by net profit margin expansion to 8.3% from significantly lower levels in the prior year. Operating margin of 12.4% demonstrates effective cost management and operational efficiency gains. ROA reached 5.2%, reflecting improved asset utilization. The DuPont decomposition shows net profit margin of 8.3%, asset turnover of 0.627, and financial leverage of 1.93, with margin improvement being the primary driver of ROE expansion. [Cash Quality] Cash and deposits totaled 10.9B yen, covering short-term debt 1.56 times, providing surface-level liquidity comfort. However, accounts receivable increased to 12.1B yen (up 49.1% YoY) while revenue remained flat, indicating collection challenges. Days Sales Outstanding extended to 156 days, substantially exceeding typical collection periods. [Investment Efficiency] Asset turnover of 0.627 indicates moderate asset utilization. Inventory reached 17.4B yen, representing 38.7% of total assets, with Days Inventory Outstanding at 363 days signaling potential obsolescence risks or strategic stockpiling. Cash Conversion Cycle extended to 481 days, reflecting severe working capital inefficiency. [Financial Health] Equity ratio of 52.1% indicates solid capitalization. Current ratio of 245.1% and quick ratio of 143.9% suggest adequate short-term liquidity on paper. However, short-term liabilities represent 82.2% of total liabilities, with short-term borrowings surging to 7.0B yen from 1.0B yen YoY (up 600%), raising refinancing concerns. Debt-to-equity ratio of 0.93 and debt-to-capital ratio of 26.7% remain conservative.
Cash and deposits increased 2.5B yen YoY to 10.9B yen, representing 29.9% growth. However, this increase coincided with a 6.0B yen surge in short-term borrowings, suggesting the cash accumulation stems primarily from debt funding rather than operational cash generation. Accounts receivable expanded 4.0B yen (49.1%) despite flat revenue, indicating deteriorating collection efficiency and cash conversion quality. Inventory maintained elevated levels at 17.4B yen, absorbing significant working capital. The 4.0B yen increase in accounts payable partially offset working capital pressure through extended supplier payment terms. Total assets increased 8.3B yen to 45.0B yen, with working capital expanding to 25.0B yen. The relationship between equity growth of 2.0B yen and net income of 2.3B yen suggests minimal dividend payments and retained earnings accumulation. The absence of operating cash flow disclosure prevents direct assessment of earnings quality, but balance sheet movements indicate working capital absorption is consuming operating cash generation, with short-term debt filling the funding gap.
Ordinary income of 3.4B yen compared to operating income of 3.5B yen indicates a modest net non-operating expense of approximately 0.1B yen. Non-operating items comprised primarily foreign exchange losses of 11M yen and interest expenses of 2M yen, with minimal impact from equity method gains or other investments. Non-operating expenses represented less than 1% of revenue, indicating core operating activities drive earnings. The minimal gap between operating and ordinary income suggests earnings quality is not materially distorted by non-recurring non-operating items. However, the absence of operating cash flow data prevents verification of accruals quality. The substantial expansion in accounts receivable (49.1%) against flat revenue raises concerns about revenue recognition timing or credit term extensions that may inflate reported earnings without corresponding cash realization. The 156-day DSO and 363-day DIO suggest significant accrual build-up in working capital, which typically indicates lower earnings quality when not validated by operating cash generation.
Full-year guidance projects revenue of 90.0B yen (up 1.8% YoY), operating income of 2.75B yen (up 1.7% YoY), ordinary income of 2.6B yen (up 8.7% YoY), and net income of 4.0B yen (up 105.7% YoY). Q1 revenue of 28.2B yen represents 31.3% of the annual target, modestly ahead of the standard 25% quarterly pace, suggesting seasonal strength in the first quarter or conservative full-year planning. However, Q1 operating income of 3.5B yen already exceeds the full-year target of 2.75B yen by 127.3%, indicating significant guidance inconsistency. This 127% progress rate against standard Q1 expectation of 25% suggests either substantial one-time benefits in Q1, expected operating losses or margin compression in remaining quarters, or understated full-year guidance requiring upward revision. The net income achievement rate of 58.5% (2.3B of 4.0B) is also ahead of schedule but more reasonable than operating income progression. Management guidance assumptions were not disclosed in available forecast notes, preventing assessment of underlying planning drivers.
Annual dividend is planned at 26.0 yen per share for the fiscal year-end, with no interim dividend. Based on Q1 net income annualized, the implied payout ratio calculates to approximately 35.9%, within sustainable parameters below 60%. However, this calculation assumes proportional earnings throughout the year, which appears inconsistent with the company's own full-year guidance showing Q1 operating profit already exceeding annual targets. If full-year net income achieves the 4.0B yen guidance, the 26.0 yen dividend would represent a healthier coverage. No share buyback activities were disclosed for the quarter. The dividend policy appears maintainable from an earnings perspective, though validation requires operating cash flow confirmation given the working capital deterioration observed. The company maintains consistent dividend payments despite the absence of interim distributions, concentrating shareholder returns at fiscal year-end.
Inventory obsolescence and write-down risk stemming from Days Inventory Outstanding of 363 days, substantially above normal manufacturing cycles. The 17.4B yen inventory balance represents 38.7% of total assets, exposing the company to demand shifts, technological obsolescence, or pricing pressures that could necessitate material impairments. Collection risk from accounts receivable expanding 49.1% to 12.1B yen against flat revenue, with DSO extending to 156 days. This pattern suggests either customer credit quality deterioration or aggressive revenue recognition practices, both of which threaten cash realization and could require bad debt provisions. Refinancing and liquidity risk from short-term borrowings increasing six-fold to 7.0B yen with 82.2% of liabilities due within one year. While current ratios appear adequate, the rapid accumulation of short-term debt alongside working capital inefficiency creates vulnerability to credit market conditions or lender relationship disruptions.
[Industry Position] (Reference - Proprietary Analysis) Profitability: Operating margin of 12.4% exceeds industry median of 6.8% (2025-Q1, manufacturing sector, n=5), placing the company in the upper quartile for operating efficiency. Net profit margin of 8.3% similarly outperforms the industry median of 6.2%, indicating stronger bottom-line conversion. ROE of 10.0% substantially exceeds the industry median of 3.9% and the interquartile range of 1.2% to 5.8%, positioning the company among top-tier performers in capital efficiency. However, this superior ROE performance is primarily margin-driven rather than asset efficiency-driven, as asset turnover of 0.627 exceeds the industry median of 0.22 but reflects the company's scale rather than operational superiority. Financial Health: Equity ratio of 52.1% exceeds the industry median of 47.5%, indicating above-median capitalization strength. Current ratio of 2.45 outperforms the industry median of 1.87, suggesting stronger liquidity positioning on the surface. Efficiency: The critical divergence emerges in working capital metrics. Days Inventory Outstanding of 363 days substantially exceeds the industry median of 201 days, indicating significantly worse inventory management. Days Sales Outstanding of 156 days falls within the industry interquartile range of 124 to 207 days but trends toward the slower end. Cash Conversion Cycle of 481 days far exceeds typical manufacturing norms, representing a fundamental operational inefficiency. Revenue declined 1.4% YoY while the industry median showed 21.0% growth, positioning the company as a laggard in top-line expansion. Source: Proprietary analysis of manufacturing sector (5 companies, 2025-Q1 comparison period).
Significant margin expansion drove strong profit growth in Q1 2025, with operating margin reaching 12.4% and ROE of 10.0% both exceeding industry medians, indicating effective cost management and operational leverage despite flat revenue conditions. However, the sustainability of this profitability improvement is questionable given the substantial deterioration in working capital efficiency, with accounts receivable increasing 49.1% against flat sales and inventory levels remaining elevated at 363 days outstanding, both substantially worse than industry norms. The six-fold increase in short-term borrowings to 7.0B yen, coupled with the absence of operating cash flow data, suggests the reported earnings growth has not translated into cash generation, raising concerns about earnings quality and creating refinancing risk with 82.2% of liabilities maturing within one year. The fundamental disconnect between Q1 operating income of 3.5B yen already exceeding full-year guidance of 2.75B yen signals either conservative guidance requiring revision or unsustainable Q1 results, warranting close monitoring of subsequent quarterly performance and potential guidance updates.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.